首页 | 本学科首页   官方微博 | 高级检索  
     

磷酸阿糖腺苷与肝炎灵治疗乙型肝炎疗效比较
引用本文:郑水根,杨金龙,匡云山. 磷酸阿糖腺苷与肝炎灵治疗乙型肝炎疗效比较[J]. 中国新药与临床杂志, 1995, 0(5)
作者姓名:郑水根  杨金龙  匡云山
作者单位:上海市第八人民医院传染科
摘    要:目的:比较磷酸阿糖腺苷与肝炎灵对乙型肝炎的疗效。方法:慢性乙型肝炎60例,采用磷酸阿糖腺苷治疗30例(男性27例,女性3例,年龄32±s7a),d1-5,10mg/kg,im,qd,d6-28,5mg/kg,im,qd。对照组30例(男性26例,女性4例,年龄30±8a),用肝炎灵4mL,im,qd,共4wk。结果:HBeAg和HBV-DNA阴转率、抗HBe阳转率治疗组分别为23%,18%,13%;对照组分别为3%,0,0(P<0.05)。结论:磷酸阿糖腺苷治疗慢性乙型肝炎,具有抑制乙型肝炎病毒(HBV)复制的作用,疗效优于肝炎灵。不良反应轻微。

关 键 词:磷酸阿糖腺苷;阿糖呋喃腺苷-磷酸盐;肝炎灵;中草药;乙型肝炎

Vidarabine phosphate vs Gan-yan-ling in treating hepatitis B
ZHENG Shui-Gen, YANG Jin-Long, KUANG Yun-Shan. Vidarabine phosphate vs Gan-yan-ling in treating hepatitis B[J]. Chinese Journal of New Drugs and Clinical Remedies, 1995, 0(5)
Authors:ZHENG Shui-Gen   YANG Jin-Long   KUANG Yun-Shan
Abstract:AIM: To compare the effect of vidarabine phostphate(Ara-AMP) with Gan-yan一ling in treating hepatitis B. METHODS: Ara-AMP group(30 patients, M 27, F 3; age 32±s 7 a, dose 10 mg/ kg, im, qd for 5 d and 5 mg / kg, im, qd for 23 d) vs Gan-yan-ling control group(30 patients, M 26, F 4; age 30±8 a, dose 4 mL, im, qd for 28 d) in treating chronic hepatitis B. RESULTS: The negative conversion rates of serum HBeAg, HBV-DNA and the positive conversion rate of serum HBeAb were 23%, 18% and 13% respectively in the former group, and 3, 0 and 0 in the later group(P<0.05). CONCLUSION: Ara-AMP is effective in inhibiting hepatitis B virus(HBV) replication and is bet ter than Gan-yan-ling. Adverse reactions are mild.
Keywords:vidarabine phosphate  arabinofuranosyladenosine monophosphate  Gan-yan-ling   Chinese herbal drugs  hepatitis B
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号